Anti-PGE antibodies inhibit in vivo development of cell-mediated immunity

A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2005

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

Journal of neurology·2004

The Trunk Impairment Scale: a new tool to measure motor impairment of the trunk after stroke.

Clinical rehabilitation·2004

The growth response to tumour necrosis factor alpha of human gynaecological cancer cell lines.

Cytokine·1998

Maturation of Qa-1b class I molecules requires beta 2-microglobulin but is TAP independent.

Journal of immunology (Baltimore, Md. : 1950)·1998

Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide.

European journal of immunology·1997

Population-scale immune multiome atlas reveals regulatory disease mechanisms.

Nature·2026

A TBK1/ULK1 signalling axis couples lysosomal stress to TFEB activation.

Nature·2026

Type 2 immune history trains lung macrophages for viral disease tolerance.

Nature·2026

Sugar-rich foods exacerbate antibiotic-induced microbiome disruption.

Nature·2026

Osteoclasts intercept meningeal lymphatic paths for dural metastasis.

Nature·2026

Self-aligned optical microcomb emerging between octave-separated lasers.

Nature·2026

Toll-like receptors 7 and 8 as therapeutic targets for human diseases.

International immunology·2026

Self-Assembling Peptide-Adjuvant Conjugate (SaPAC) Platform for Precision Cancer Immunotherapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Optimizing antibody-dependent cellular phagocytosis for cancer immunotherapy: mechanisms, constraints, and therapeutic strategies.

Journal of advanced research·2026

Jianwei Shoutai Pills enhances maternal-fetal immune tolerance via regulatory T cell modulation to ameliorate uterine aging-associated early pregnancy loss.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

Related Experiment Videos

Anti-PGE antibodies inhibit in vivo development of cell-mediated immunity

Related Concept Videos

A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis.

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

The Trunk Impairment Scale: a new tool to measure motor impairment of the trunk after stroke.

The growth response to tumour necrosis factor alpha of human gynaecological cancer cell lines.

Maturation of Qa-1b class I molecules requires beta 2-microglobulin but is TAP independent.

Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide.

Population-scale immune multiome atlas reveals regulatory disease mechanisms.

A TBK1/ULK1 signalling axis couples lysosomal stress to TFEB activation.

Type 2 immune history trains lung macrophages for viral disease tolerance.

Sugar-rich foods exacerbate antibiotic-induced microbiome disruption.

Osteoclasts intercept meningeal lymphatic paths for dural metastasis.

Self-aligned optical microcomb emerging between octave-separated lasers.

Toll-like receptors 7 and 8 as therapeutic targets for human diseases.

Self-Assembling Peptide-Adjuvant Conjugate (SaPAC) Platform for Precision Cancer Immunotherapy.

Optimizing antibody-dependent cellular phagocytosis for cancer immunotherapy: mechanisms, constraints, and therapeutic strategies.

Jianwei Shoutai Pills enhances maternal-fetal immune tolerance via regulatory T cell modulation to ameliorate uterine aging-associated early pregnancy loss.

Related Experiment Videos

Anti-PGE antibodies inhibit in vivo development of cell-mediated immunity

Related Concept Videos

Related Articles